Pfizer
Danish court overturns Lipitor patent challenge
September 5, 2008Sales and Marketing Denmark, Lipitor, Pfizer, generics
A court in Denmark has ruled in favour of Pfizer in challenges to patents on the active ingredient – atorvastatin …
Pfizer to co-market new Alzheimer’s drug
September 5, 2008Sales and Marketing Alzheimer's, Pfizer
Pfizer is to partner with American firm Medivation to develop and market a new drug for Alzheimer’s and Huntington’s disease.The …
Latest news from Datamonitor
September 1, 2008Research and Development Pfizer
Pfizer: changes in R&D structure expected to increase number of late stage productsPharmaceutical giant Pfizer has announced that it intends …
Groundbreaking pharma-NHS collaboration launched in Nottingham
May 30, 2008ABPI, ABPI Outreach Programme, AstraZeneca, Boehringer Ingelheim, COPD, GlaxoSmithKline, INFORCE, Nottingham, Nycomed, Pfizer, joint working
A group of pharmaceutical companies have joined forces with Nottingham healthcare services to help improve care for patients with chronic …
Pfizer invests in oncology for future gains
May 16, 2008Research and Development, Sales and Marketing Cancer, Pfizer
Pfizer has named Garry Nicholson as head of its new global oncology unit, a venture the company believes will bring …
Pfizer abandons Exubera
October 19, 2007Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin
Once predicted to be a blockbuster, inhaled insulin product Exubera is to be abandoned by Pfizer because of poor sales.Exubera …
Wyeth names new chief executive
October 10, 2007Sales and Marketing Pfizer, Wyeth
Wyeth will begin 2008 with a new leader at the helm. Bernard Poussot will become the company's elected president and …
Pfizer appoints new finance chief
August 23, 2007Sales and Marketing Pfizer
Pfizer has appointed Frank D'Amelio as its new head of finance, and says he has a strong track record in …
Latest news from Datamonitor
June 22, 2007Research and Development, Sales and Marketing NSCLC, Novartis, Pfizer
Novartis receives FDA approval for blood pressure medicineNovartis has been granted final FDA approval for Exforge, its high blood pressure …
Pfizer’s torcetrapib results cast doubt on CETP inhibitors
March 30, 2007Research and Development, Sales and Marketing Pfizer, lipid
New data on Pfizer's ill-fated torcetrapib suggest the drug doesn't reduce arterial plaque, casting doubt on other drugs in the …
Exubera approval limited to needle-phobic patients
January 26, 2007Sales and Marketing Exubera, NICE, Pfizer, diabetes, inhaled insulin
Diabetes patients who are genuinely needle-phobic will be among the few to be given Pfizer’s inhaled insulin product Exubera on …
Kindler sets out new vision for Pfizer
December 1, 2006Sales and Marketing Pfizer, lipid
Pfizer's chief executive Jeffrey Kindler has set out plans for the company to renew itself as an R&D, in-licensing and …
Pfizer cuts 2,200 US sales reps
December 1, 2006Sales and Marketing Pfizer, US, job cuts, salesforce
Pfizer has announced a cut of 20% to its US salesforce, a move it says will help it adapt to …
Pfizer buys British vaccine company PowderMed
October 12, 2006Research and Development Pfizer, Powdermed, vaccines
Pfizer will gain entry into the fast-growing vaccines market by buying PowderMed, the British company developing next generation products in …
McKinnell makes early exit from Pfizer
August 3, 2006Sales and Marketing Pfizer
Hank McKinnell has stepped down as chief executive of Pfizer earlier than expected following continued criticism of his performance from …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
